ACE inhibitors are beneficial for many patients at risk for heart disease

December 1999

A new landmark study shows that ACE inhibitors are beneficial for many patients at risk for heart disease.

We already know they improve survival in patients with systolic heart failure...or a recent MI.

Now there's evidence the ACE inhibitor ramipril (Altace) reduces morbidity and mortality for a broad spectrum of patients with atherosclerosis or diabetes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote